Fountain Healthcare Partners
Fountain Healthcare Partners is a private equity and venture capital firm based in Dublin, Ireland, with an additional office in New York. Established in 2008, the firm specializes in investments within the life sciences sector, focusing on areas such as biotechnology, biopharmaceuticals, specialty pharmaceuticals, medical devices, and diagnostics. Fountain Healthcare Partners primarily invests in early-stage and mid-stage companies, typically committing between €0.5 million and €10 million. The firm predominantly directs its capital towards opportunities in the United States and Europe, with a particular emphasis on Ireland, where it often seeks to lead or co-lead investments. The firm aims to exit its investments within three to five years, typically through an initial public offering or trade sale, and actively seeks a seat on the board of its portfolio companies.
MMI S.r.l. is an Italian company that specializes in the manufacture and development of advanced micro instruments designed for surgical interventions. Founded in 2015 and based in Calci, Italy, MMI focuses on creating wristed micro instruments and their associated fabrication processes. The company also offers a proprietary robotic platform that enhances the capabilities of these instruments, facilitating complex reconstruction procedures following traumatic injuries and tumor removals in areas such as the breast, head, and bones. MMI aims to support surgeons globally by providing innovative tools that improve surgical outcomes while also reducing costs for patients and healthcare systems.
Neuromod Devices Limited is a medical device company based in Dublin, Ireland, established in 2010. It focuses on the research and development of neuromodulation treatments, specifically targeting chronic tinnitus, a condition that affects approximately 10% of adults. The company's flagship product, the mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the nervous system. Neuromod aims to provide effective treatments for underserved patient populations suffering from chronic and debilitating conditions, enabling them to manage their health more effectively. The company has developed and patented its bi-modal neuromodulation technology, which is also being explored for other neurological disorders.
Neuromod Devices Limited is a medical device company based in Dublin, Ireland, established in 2010. It focuses on the research and development of neuromodulation treatments, specifically targeting chronic tinnitus, a condition that affects approximately 10% of adults. The company's flagship product, the mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the nervous system. Neuromod aims to provide effective treatments for underserved patient populations suffering from chronic and debilitating conditions, enabling them to manage their health more effectively. The company has developed and patented its bi-modal neuromodulation technology, which is also being explored for other neurological disorders.
MMI S.r.l. is an Italian company that specializes in the manufacture and development of advanced micro instruments designed for surgical interventions. Founded in 2015 and based in Calci, Italy, MMI focuses on creating wristed micro instruments and their associated fabrication processes. The company also offers a proprietary robotic platform that enhances the capabilities of these instruments, facilitating complex reconstruction procedures following traumatic injuries and tumor removals in areas such as the breast, head, and bones. MMI aims to support surgeons globally by providing innovative tools that improve surgical outcomes while also reducing costs for patients and healthcare systems.
Neuromod Devices Limited is a medical device company based in Dublin, Ireland, established in 2010. It focuses on the research and development of neuromodulation treatments, specifically targeting chronic tinnitus, a condition that affects approximately 10% of adults. The company's flagship product, the mutebutton, is a bi-modal neuromodulation device designed to promote positive therapeutic changes in the nervous system. Neuromod aims to provide effective treatments for underserved patient populations suffering from chronic and debilitating conditions, enabling them to manage their health more effectively. The company has developed and patented its bi-modal neuromodulation technology, which is also being explored for other neurological disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.